UPDATE: Chardan Capital Markets Starts Pear Therapeutics (PEAR) at Buy
Tweet Send to a Friend
(Updated - December 22, 2021 7:22 AM EST)
Chardan Capital Markets analyst Keay Nakae initiates coverage on Pear Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Chardan Capital Markets analyst Keay Nakae initiates coverage on Pear Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
